Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Coinbase Dogecoin Sweepstakes: What to Know About the $1.2M DOGE Giveaway

Here's the low-down on what investors will want to know about the recently launched Coinbase Dogecoin Sweepstakes.

OCGN stock: The Big COVAXIN News Boosting Ocugen Today

Today, OCGN stock is on the move as the company announced its intention to expand its commercialization rights to include Canada.

CCIV Stock: The EV News That Has Churchill Capital Gaining Today

Today, CCIV stock is on the move as investors price in a range of bullish catalysts, including the cancellation of Tesla's Plaid+ model.

FCEL Stock: Upcoming Earnings and Short-Squeeze Hopes Are Lifting FuelCell Energy

Today, FCEL stock is surging more than 15% as retail investors pile into this short squeeze opportunity ahead of the company's earnings.

ATOS Stock: What Is the Big Catalyst for Atossa Therapeutics on June 9?

Today, ATOS stock is taking off on the veiled announcement of the release of some Phase 2 study data for one of the company's leading drugs.